ALEXANDRIA, Va., April 15 -- United States Patent no. 12,602,338, issued on April 14, was assigned to Silicon Laboratories Inc. (Austin, Texas). "Software interrupt management system for symmetric mu... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,602,339, issued on April 14, was assigned to Dell Products LP (Round Rock, Texas). "Strain relief for floating card electromechanical connecto... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,770, issued on April 14, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany). "Antibodies to connective ... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,771, issued on April 14, was assigned to CONNECT BIOPHARMA HONGKONG Ltd. (Kowloon, Hong Kong). "Antibody for binding to interleukin 4 rece... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,772, issued on April 14, was assigned to Motokazu Kato (Osaka, Japan). "Therapeutic agent for asthma containing IL-6 inhibitor" was invent... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,773, issued on April 14, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark) and Yale University (New Haven, Conn.). "Treatment of diure... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,774, issued on April 14, was assigned to Shijiazhuang Yiling Pharmaceutical Co. Ltd. (Shijiazhuang, China). "Monoclonal antibodies against... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,775, issued on April 14, was assigned to Kite Pharma Inc. (Santa Monica, Calif.). "Chimeric antigen receptor T cell therapy" was invented ... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,776, issued on April 14, was assigned to CARTEXELL INC. (Seoul, South Korea). "Anti-L1CAM antibody or antigen-binding fragment thereof and... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,777, issued on April 14, was assigned to Novartis AG (Basel, Switzerland) and Immutep S.A.S. (Orsay, France). "Combination therapies compr... Read More